Free Trial

Bullfrog AI (BFRG) Competitors

Bullfrog AI logo
$1.21 -0.02 (-1.63%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$1.22 +0.01 (+0.41%)
As of 08/29/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BFRG vs. VTVT, LTRN, ANVS, JSPR, KLRS, BRNS, STTK, TELO, TPST, and KLTO

Should you be buying Bullfrog AI stock or one of its competitors? The main competitors of Bullfrog AI include vTv Therapeutics (VTVT), Lantern Pharma (LTRN), Annovis Bio (ANVS), Jasper Therapeutics (JSPR), Kalaris Therapeutics (KLRS), Barinthus Biotherapeutics (BRNS), Shattuck Labs (STTK), Telomir Pharmaceuticals (TELO), Tempest Therapeutics (TPST), and Klotho Neurosciences (KLTO). These companies are all part of the "pharmaceutical products" industry.

Bullfrog AI vs. Its Competitors

Bullfrog AI (NASDAQ:BFRG) and vTv Therapeutics (NASDAQ:VTVT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, media sentiment, valuation, risk and dividends.

vTv Therapeutics has a consensus price target of $35.50, suggesting a potential upside of 128.66%. Given vTv Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe vTv Therapeutics is more favorable than Bullfrog AI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bullfrog AI
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
vTv Therapeutics
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

1.0% of Bullfrog AI shares are owned by institutional investors. Comparatively, 17.5% of vTv Therapeutics shares are owned by institutional investors. 24.7% of Bullfrog AI shares are owned by insiders. Comparatively, 1.3% of vTv Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Bullfrog AI has higher earnings, but lower revenue than vTv Therapeutics. vTv Therapeutics is trading at a lower price-to-earnings ratio than Bullfrog AI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bullfrog AI$60K203.28-$6.99M-$0.76-1.59
vTv Therapeutics$1.02M48.55-$18.46M-$3.12-4.98

Bullfrog AI has a beta of 0.47, indicating that its stock price is 53% less volatile than the S&P 500. Comparatively, vTv Therapeutics has a beta of 0.64, indicating that its stock price is 36% less volatile than the S&P 500.

In the previous week, Bullfrog AI and Bullfrog AI both had 1 articles in the media. vTv Therapeutics' average media sentiment score of 1.88 beat Bullfrog AI's score of 0.93 indicating that vTv Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Bullfrog AI Positive
vTv Therapeutics Very Positive

vTv Therapeutics' return on equity of -179.75% beat Bullfrog AI's return on equity.

Company Net Margins Return on Equity Return on Assets
Bullfrog AIN/A -195.35% -162.37%
vTv Therapeutics N/A -179.75%-55.91%

Summary

vTv Therapeutics beats Bullfrog AI on 9 of the 14 factors compared between the two stocks.

Get Bullfrog AI News Delivered to You Automatically

Sign up to receive the latest news and ratings for BFRG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BFRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BFRG vs. The Competition

MetricBullfrog AIMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$12.20M$2.05B$5.69B$9.74B
Dividend YieldN/AN/A6.66%4.48%
P/E Ratio-1.5938.0183.1926.59
Price / Sales203.289.61515.50159.17
Price / CashN/A52.0425.6628.92
Price / Book2.1210.7911.716.08
Net Income-$6.99M-$63.67M$3.27B$265.93M
7 Day Performance-1.63%-0.71%1.13%0.36%
1 Month Performance-6.92%10.44%8.30%5.58%
1 Year Performance-53.10%30.31%62.26%19.67%

Bullfrog AI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BFRG
Bullfrog AI
0.7835 of 5 stars
$1.21
-1.6%
N/A-53.1%$12.20M$60K-1.594
VTVT
vTv Therapeutics
2.0172 of 5 stars
$15.35
-4.1%
$35.50
+131.3%
-1.2%$48.95M$1.02M-4.929Gap Down
LTRN
Lantern Pharma
2.7725 of 5 stars
$4.49
-1.9%
$25.00
+457.4%
-0.2%$48.49MN/A-2.5220
ANVS
Annovis Bio
1.9007 of 5 stars
$2.46
+9.8%
$18.00
+631.7%
-72.6%$47.94MN/A-1.213Gap Up
JSPR
Jasper Therapeutics
3.2762 of 5 stars
$2.94
-0.7%
$28.75
+877.9%
-87.2%$47.78MN/A-0.4920
KLRS
Kalaris Therapeutics
0.9551 of 5 stars
$2.55
+1.6%
$3.00
+17.6%
N/A$47.69MN/A0.00110Positive News
BRNS
Barinthus Biotherapeutics
2.8982 of 5 stars
$1.17
-2.1%
$3.00
+156.4%
-14.5%$47.64M$14.97M-0.68107Positive News
Gap Up
STTK
Shattuck Labs
3.4854 of 5 stars
$0.99
+0.0%
$7.00
+604.2%
-72.7%$47.62M$3.00M-0.82100Gap Down
TELO
Telomir Pharmaceuticals
2.4571 of 5 stars
$1.47
+0.7%
$15.00
+920.4%
-74.8%$47.45MN/A-2.721Gap Down
TPST
Tempest Therapeutics
1.9463 of 5 stars
$10.58
+0.1%
$30.00
+183.4%
-40.8%$46.84MN/A-0.7220Positive News
KLTO
Klotho Neurosciences
N/A$0.76
+0.5%
N/AN/A$46.49MN/A-1.68N/A

Related Companies and Tools


This page (NASDAQ:BFRG) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners